AMERICAN TOWER CORP /MA/ (AMT)
The Board declared a cash distribution of $1.79 per share to shareholders, which is material to investors as it affects shareholder returns and cash flow.
View raw filing on EDGAR →SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Board declared a cash distribution of $1.79 per share to shareholders, which is material to investors as it affects shareholder returns and cash flow.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from IDACORP's 2026 Annual Meeting held on May 21, 2026. The filing reports voting outcomes on three proposals: election of ten directors (all approved), advisory approval of executive compensation (approved), and ratification of Deloitte & Touche LLP as independent auditor (approved). Shareholder meeting results are material to investors as they reflect governance decisions and confirm board composition and auditor appointment.
View raw filing on EDGAR →Cognizant drew $1 billion under its revolving credit facility on May 20, 2026, creating a direct financial obligation under Item 2.03. While this is a material debt incurrence that would affect investor assessment of liquidity and leverage, it does not fit neatly into the more specific event categories (covenant_breach, going_concern, or dilutive_issuance). The filing discloses a routine credit facility draw rather than a breach, distress signal, or equity issuance, making "other_material" the most appropriate classification.
View raw filing on EDGAR →Starfighters Space, Inc. issued a news release on May 20, 2026 reporting financial results for Q1 fiscal year 2026 (period ended March 31, 2026), with the release attached as Exhibit 99.1 and financial statements available on the company's website and SEC EDGAR.
View raw filing on EDGAR →Sphere 3D Corp. held a Special Meeting of Shareholders on May 15, 2026, and disclosed voting results on five proposals including share issuance for an acquisition, board size and director elections, incentive plan amendments, and share consolidation. The voting results (For, Against, Withheld, Broker Non-Votes) were reported for each proposal via press release on May 21, 2026.
View raw filing on EDGAR →Joe W. Laymon resigned from the Board of Directors effective immediately due to personal health reasons, vacating his committee memberships. This is a clear director departure disclosure under Item 5.02, and board-level departures are material to investors assessing governance and continuity.
View raw filing on EDGAR →Nocopi Technologies' subsidiary entered into and completed a material asset purchase agreement on May 18, 2026, acquiring substantially all assets of Polymeric U.S., Inc.'s business for $2.65 million in aggregate consideration (cash, assumed liabilities, and 500,000 common shares). The acquisition was funded in part by a concurrent private placement of 266,668 shares at $1.50/share.
View raw filing on EDGAR →Nocopi Technologies issued unregistered equity securities comprising 500,000 consideration shares to the seller and 266,668 placement shares to accredited investors, totaling 766,668 shares, under Section 4(a)(2) exemption. The placement shares were issued at $1.50/share to fund the Polymeric U.S., Inc. acquisition.
View raw filing on EDGAR →Kimberly Nelson, the former Executive Vice President and Chief Financial Officer, is retiring effective June 1, 2026. Although the filing also mentions Joseph Del Preto's prior appointment as her successor (March 16, 2026), the principal disclosed action in this Item 5.02 section is Ms. Nelson's departure—the determination of her retirement date and the waiver of the six-month notice requirement to allow her equity awards to be treated under retirement provisions. The departure of a CFO is material to investors.
View raw filing on EDGAR →Deere & Company disclosed its second quarter fiscal 2026 results of operations via a press release (Exhibit 99.1) furnished under Item 2.02, accompanied by an investor presentation under Item 7.01 in connection with an earnings call on May 21, 2026.
View raw filing on EDGAR →The disclosure reveals material clinical development information about NanoViricides' drug candidates, including that NV-387 is "now entering Phase II clinical trial against Mpox in DRC" and that the company has developed an oral formulation of remdesivir encapsulated in NV-387 nanoviricide micelles with demonstrated efficacy in animal models. The company also states it has "a clinical site in DRC for treatment of Mpox patients." This represents significant clinical progress and pipeline advancement that would affect a reasonable investor's assessment of the company's development stage and commercial prospects, but does not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, impairment, or litigation).
View raw filing on EDGAR →This Item 5.07 filing discloses the results of two shareholder votes held on May 20, 2026: a Court Meeting of Scheme Shares and a General Meeting of shareholders, both approving a Scheme of Arrangement (a merger/acquisition transaction). The overwhelming approval rates (99.98% in favor at both meetings) and the explicit statement that "All matters submitted to a vote of the Company's stockholders...were approved" directly match the shareholder_vote_results event type. This is material as it represents shareholder approval of a significant corporate transaction.
View raw filing on EDGAR →AvalonBay Communities entered into a definitive merger agreement with Equity Residential in an all-stock merger-of-equals transaction at an exchange ratio of 2.793 Equity Residential shares per AvalonBay share, announced on May 21, 2026. The transaction includes governance arrangements and equity award conversions, representing a material combination of two major REITs.
View raw filing on EDGAR →John Deere Capital Corporation disclosed quarterly and year-to-date financial results for Q2 and the first six months of fiscal 2026, including revenue, net income, and ending portfolio balance, along with Deere & Company's parent company press release and supporting presentation materials.
View raw filing on EDGAR →Mayville Engineering entered into an underwriting agreement on May 19, 2026 to issue 4,348,000 shares of common stock at $20.00 per share, plus an additional 652,000 shares from a fully exercised option, generating approximately $93.9 million in net proceeds. The offering was announced via press release filed as a Regulation FD disclosure.
View raw filing on EDGAR →S&P Global's Board approved the separation of its Mobility division through a pro rata distribution of 100% of Mobility Global shares to shareholders, with an effective date of July 1, 2026. This constitutes a material change of control and disposition event—the company is divesting a major business unit and spinning it off as an independent public company. While technically a "spin-off" rather than a traditional M&A transaction, it represents a fundamental restructuring that materially affects the registrant's asset base and shareholder value, falling squarely within the ma_activity category.
View raw filing on EDGAR →Rigetti Computing completed an unregistered private offering of equity securities in reliance on Section 4(a)(2) and/or Regulation D exemptions, resulting in dilution to existing shareholders.
View raw filing on EDGAR →Rigetti's wholly-owned subsidiary entered into a non-binding Letter of Intent with the U.S. Department of Commerce for a $100 million CHIPS and Science Act award over three years, contingent on negotiating definitive agreements and involving issuance of common stock to the Department at a discounted price.
View raw filing on EDGAR →The disclosure announces completion of an FDA meeting regarding zervimesine for dementia with Lewy bodies patients with psychosis. This represents a material regulatory milestone for a clinical-stage biopharmaceutical company, but does not fit neatly into more specific categories (not an earnings release, M&A activity, or litigation). FDA meeting outcomes can materially affect development timelines and investor expectations for drug candidates.
View raw filing on EDGAR →The Board appointed Glenn Wright as an independent director effective May 26, 2026, and assigned him to the Finance and Risk Management Committee. Wright is a former Shell executive with relevant energy industry experience.
View raw filing on EDGAR →John Livingston was elected and appointed as a new director of the Board effective May 19, 2026, with concurrent appointments to the Audit, Finance and Risk Committee and Compensation and Leadership Development Committee. The appointment includes an annual retainer of $50,000, committee fees, and 5,896 RSUs.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Sierra Bancorp's annual meeting held May 20, 2026. The filing reports voting outcomes on three proposals: election of directors (with detailed vote tallies for each nominee), ratification of Forvis Mazars, LLP as independent auditor (98.23% approval), and advisory vote on executive compensation (96.38% approval). The detailed vote counts and percentages are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →CNH Capital Receivables LLC entered into material definitive agreements (Underwriting Agreement and Trust Agreement) in connection with a $907.68 million asset-backed securitization issuance by CNH Equipment Trust 2026-B, materially affecting the registrant's capital structure and financial obligations.
View raw filing on EDGAR →This is a clear Item 5.07 disclosure of shareholder vote results from Reliance, Inc.'s Annual Meeting of Stockholders held on May 20, 2026. The filing reports voting outcomes on four matters: election of nine directors, advisory approval of named executive officer compensation, ratification of KPMG LLP as independent auditor, and a stockholder proposal on director tenure. These are routine but material governance matters that affect investor understanding of board composition and corporate oversight.
View raw filing on EDGAR →KKR FS Income Trust Select issued 195,291.294 Class I shares for approximately $4.894 million in an unregistered private offering relying on Section 4(a)(2) of the Securities Act and Regulation D, diluting existing shareholders' ownership.
View raw filing on EDGAR →KKR FS Income Trust issued 206,091.447 Class I shares for approximately $6.024 million in an unregistered private offering under Section 4(a)(2) of the Securities Act and Regulation D, diluting existing shareholders' ownership.
View raw filing on EDGAR →The Company disclosed its net asset value per Class I Share of $29.23 as of April 30, 2026 (aggregate NAV ~$1.582 billion) and reported that its ongoing private offering has raised $1.667 billion of a $5.0 billion target.
View raw filing on EDGAR →The filing discloses the closing of a subscription offering in connection with the conversion of Pioneer Federal Savings and Loan Association to a stock bank and the establishment of PSB Financial as its holding company, with the Company's common stock commencing quotation on OTCQB under symbol "PNSB" on May 22, 2026. While this represents a significant corporate restructuring and capital event, it does not fit neatly into the more specific event categories (it is not a traditional M&A activity, dilutive issuance, or earnings release), making "other_material" the most appropriate classification for this material conversion and initial public quotation event.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the Company's 2026 Annual Meeting of Stockholders held on May 18, 2026, filed under Item 5.07. The filing reports voting outcomes on three proposals: election of ten directors, ratification of Deloitte & Touche LLP as independent auditor, and an advisory vote on named executive officer compensation. All proposals passed with strong majorities (89–99% support), making this a material governance event that affects investor understanding of board composition and audit oversight.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from California Water Service Group's Annual Meeting of Stockholders held on May 20, 2026. The filing reports voting outcomes on three matters: (1) election of 11 directors, (2) advisory vote on named executive officer compensation, and (3) ratification of Deloitte & Touche LLP as independent auditor. This is the quintessential shareholder_vote_results event type under Item 5.07.
View raw filing on EDGAR →Shawn Canter, Chief Financial Officer of KULR Technology Group, resigned effective May 22, 2026, pursuant to a Separation Agreement. While the disclosure includes compensatory terms (severance, cooperation payments), the principal disclosed action is the departure of a named executive officer from a C-suite position, making exec_departure the most salient classification. The CFO role is material to investor assessment of the company's financial oversight and governance.
View raw filing on EDGAR →Merchants Bancorp held its Annual Meeting of Shareholders on May 21, 2026, with voting results disclosed for three matters: election of twelve directors, a non-binding advisory vote on named executive officer compensation, and ratification of Forvis Mazars, LLP as the independent auditor.
View raw filing on EDGAR →This Item 5.07 disclosure reports the results of Solid Power's 2026 annual meeting of stockholders held on May 20, 2026, including election of three Class II directors (Steven Goldberg, Aleksandra Miziolek, and MaryAnn Wright), ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed voting tallies for each matter are provided, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →The disclosure announces EXIM Board approval of a $2.9 billion senior secured long-term loan to support development of the Stibnite Gold Project. While this is a material financing event that would significantly affect investor assessment of the company's capital structure and project funding, it does not fit cleanly into the standard M&A taxonomy categories. The event is neither a traditional acquisition/disposition nor a debt covenant breach or going-concern disclosure, making "other_material" the most appropriate classification for this major project financing approval.
View raw filing on EDGAR →Target Hospitality Corp. held its 2026 Annual Meeting of Stockholders on May 21, 2026, with shareholders voting on four proposals: election of six directors, ratification of Ernst & Young LLP as independent auditor, advisory say-on-pay vote on named executive officer compensation, and approval of a 4,000,000 share increase to the 2019 Incentive Award Plan. All proposals passed with substantial majorities ranging from 85.45% to 99.95% approval.
View raw filing on EDGAR →On May 21, 2026, Target Hospitality Corp. awarded restricted stock units (RSUs) to non-employee directors, with the award agreement filed as an exhibit. This material equity compensation grant to directors reflects the company's director compensation arrangements.
View raw filing on EDGAR →Mohawk Industries held its Annual Meeting on May 21, 2026, with shareholders voting on four matters: election of three directors, ratification of KPMG LLP as independent auditor, advisory vote on named executive officer compensation, and approval of the 2026 Incentive Plan.
View raw filing on EDGAR →Rithm Capital held its Annual Meeting of Stockholders with voting results on multiple matters: election of two Class I directors (David Saltzman and William D. Addas), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the First Amendment to the 2023 Omnibus Incentive Plan increasing reserved shares by 35 million.
View raw filing on EDGAR →Citigroup held its 2026 Annual Meeting of Stockholders on May 20, 2026, with voting results disclosed on four matters: election of 13 directors, ratification of KPMG LLP as independent auditor, advisory vote on 2025 executive compensation, and approval of an amendment to the 2019 Stock Incentive Plan increasing authorized shares by 20 million.
View raw filing on EDGAR →The Company entered into a new $1.2 billion Five-Year Revolving Credit Agreement on May 15, 2026, replacing a prior $1.0 billion facility. While this represents a material refinancing and increase in available liquidity, it does not fit neatly into the more specific event categories (ma_activity applies to acquisitions/dispositions, not credit facility amendments; covenant_breach applies to violations, not new covenant establishment). The disclosure is material to investors as it affects the Company's financial flexibility and capital structure, but the event is best classified as other_material given the absence of a dedicated taxonomy entry for credit facility amendments or refinancings.
View raw filing on EDGAR →C. Taylor Pickett (CEO) and Robert O. Stephenson (CFO) are departing the company, effective October 1, 2026 and August 1, 2026 respectively. The filing discloses transition and consulting agreements for both executives, representing a material change in the company's top leadership.
View raw filing on EDGAR →ClearSign Technologies disclosed quarterly financial results for the quarter ended March 31, 2026 via a press release issued on May 20, 2026, along with a conference call transcript discussing the results.
View raw filing on EDGAR →Adagio Medical submitted a Premarket Approval (PMA) application to the FDA for its vCLAS® Ventricular Ablation System, a significant regulatory milestone for a medical device company. This event is material to investors as FDA approval is a critical path to commercialization and revenue generation, but it does not fit neatly into the more specific event categories (not an earnings release, M&A activity, impairment, litigation, or other defined types). The submission of a major regulatory application represents a material corporate development warranting disclosure under Item 8.01.
View raw filing on EDGAR →The filing discloses the appointment of Troy Taylor, age 54, to the position of Chief Operating Officer (COO) effective May 20, 2026. This is a material executive appointment under Item 5.02, as the COO is a senior officer responsible for leadership and strategic direction. The filing explicitly states no material compensatory arrangements were entered into, making the appointment itself—not compensation—the principal disclosed event.
View raw filing on EDGAR →The filing discloses Item 5.07 results from Walker & Dunlop's 2026 Annual Meeting of Stockholders held on May 19, 2026, including voting outcomes on three matters: election of eight directors, ratification of KPMG LLP as independent auditor, and an advisory vote on executive compensation. These are standard shareholder vote results that materially inform investors about board composition and governance approvals.
View raw filing on EDGAR →The filing discloses a "proposed transaction between VYNE and Yarrow" with an S-4 registration statement (File No. 333-294804) filed with the SEC, indicating a material merger or acquisition. The disclosure of an investor presentation by Yarrow Bioscience in connection with this transaction, combined with explicit references to proxy solicitation materials and stockholder voting, confirms this is M&A activity requiring 8-K disclosure under Item 1.01 or related provisions.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the Annual Meeting of Stockholders held on May 21, 2026, reporting the election of directors (James J. Brady, IV and Eric J. Heagy) and ratification of Wipfli LLP as independent auditor. Item 5.07 is the designated Item for shareholder vote results, and the filing presents final vote tallies for each matter submitted to stockholders.
View raw filing on EDGAR →The filing discloses entry into material financing arrangements: an Indenture Supplement dated May 28, 2026 for issuance of "Offered Notes" and a Risk Retention Agreement among First National Bank of Omaha, First National Funding LLC, and First National Master Note Trust. While this involves debt issuance and securitization activity, the Item 8.01 classification and absence of explicit M&A language make it distinct from standard ma_activity. The disclosure of note offerings and related indenture supplements would materially affect investor assessment of the registrant's capital structure and financing activities.
View raw filing on EDGAR →The disclosure announces initial clinical trial data (Duravelo-2) for a candidate therapeutic in metastatic urothelial cancer presented at ASCO. For a clinical-stage or development-focused biopharmaceutical company, positive or significant clinical data announcements are material to investors assessing pipeline progress and regulatory prospects. However, this does not fit neatly into the standard taxonomy categories (not earnings, M&A, impairment, litigation, etc.), warranting classification as other_material.
View raw filing on EDGAR →GCI Liberty, Inc. changed its corporate name to Liberty Capital Corporation effective May 21, 2026, through amendments to its Articles of Incorporation and Bylaws. The name change does not affect security holders' rights, trading symbols (GLIBA, GLIBB, GLIBK), or CUSIP numbers.
View raw filing on EDGAR →